Literature DB >> 20610642

NLRC5 limits the activation of inflammatory pathways.

Szilvia Benko1, Joao G Magalhaes, Dana J Philpott, Stephen E Girardin.   

Abstract

Nod-like receptors (NLRs) are intracellular sentinel proteins that are implicated in the detection of microbes and danger signals, thereby controlling several key innate immune pathways. The human genome encodes 22 NLR proteins, the function of many of which remains unknown. In this study, we present the identification and characterization of NLRC5, a NLR protein whose expression is found predominantly in cells of the myeloid and lymphoid lineages. NLRC5 expression was strongly induced by IFN-gamma and more modestly by LPS and polyinosinic:polycytidylic acid. Overexpression of NLRC5 in HEK293T cells resulted in a global dampening of NF-kappaB-, AP-1-, and type I IFN-dependent signaling, most likely through transcriptional repression. Accordingly, NLRC5 was found to shuttle between the cytosol and the nucleus in a CrmA-dependent manner. Knocking down NLRC5 expression in RAW264.7 murine macrophages resulted in a potent upregulation of the proinflammatory responses to IFN-gamma and LPS, including increased secretion of TNF, IL-6, and IL-1beta, as well as cell surface expression of CD40. Strikingly, NLRC5 expression was also found to be critical for LPS-induced IL-10 production in RAW264.7 macrophages. Collectively, our results identify NLRC5 as a negative modulator of inflammatory pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610642     DOI: 10.4049/jimmunol.0903900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  106 in total

1.  Polygenic effects of common single-nucleotide polymorphisms on life span: when association meets causality.

Authors:  Anatoliy I Yashin; Deqing Wu; Konstantin G Arbeev; Svetlana V Ukraintseva
Journal:  Rejuvenation Res       Date:  2012-04-25       Impact factor: 4.663

2.  NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.

Authors:  Yikun Yao; Yalong Wang; Fuxiang Chen; Yin Huang; Shu Zhu; Qibin Leng; Hongyan Wang; Yufang Shi; Youcun Qian
Journal:  Cell Res       Date:  2012-04-10       Impact factor: 25.617

Review 3.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

4.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

5.  Cutting edge: NLRC5-dependent activation of the inflammasome.

Authors:  Beckley K Davis; Reid A Roberts; Max T Huang; Stephen B Willingham; Brian J Conti; W June Brickey; Brianne R Barker; Mildred Kwan; Debra J Taxman; Mary-Ann Accavitti-Loper; Joseph A Duncan; Jenny P-Y Ting
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

Review 6.  Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines.

Authors:  Brianne R Barker; Debra J Taxman; Jenny P-Y Ting
Journal:  Curr Opin Immunol       Date:  2011-08-10       Impact factor: 7.486

Review 7.  NLRC5/CITA: A Key Player in Cancer Immune Surveillance.

Authors:  Sayuri Yoshihama; Saptha Vijayan; Tabasum Sidiq; Koichi S Kobayashi
Journal:  Trends Cancer       Date:  2017-01-10

Review 8.  Inflammasomes and its importance in viral infections.

Authors:  Gaurav Shrivastava; Moisés León-Juárez; Julio García-Cordero; David Eduardo Meza-Sánchez; Leticia Cedillo-Barrón
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

9.  Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Authors:  Nadeem O Kaakoush; Nandan P Deshpande; Si Ming Man; Jose A Burgos-Portugal; Faisal A Khattak; Mark J Raftery; Marc R Wilkins; Hazel M Mitchell
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

Review 10.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.